Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

Fig. 1

Cerebrospinal fluid (CSF) levels of fatty acid binding protein 3, heart type (FABP3), and tau across the diagnostic groups. a Box plots of the five biomarkers across the diagnostic groups. b, and c Correlation plots (Spearman) for the CSF five-biomarker panel in the whole cohort and in the diagnostic groups. OND Other neurological diseases, PD Parkinson’s disease, PDD Parkinson’s disease with dementia, DLB Dementia with Lewy bodies, AD Alzheimer’s disease, 1–42 Amyloid-β peptide 1–42, p-tau Phosphorylated tau 181, α-syn α-Synuclein, t-tau Total tau

Back to article page